Helping Hand Questions for MCCQE

Accurate determination of gestational age is essential, particularly in suspected preterm labour at 24 weeks. MCCQE objectives emphasize that first-trimester ultrasound , specifically measurement of the crown-rump length (CRL) at 8–12 weeks , is the most reliable method for dating a pregnancy. In early gestation, biological variation in fetal size is minimal, making CRL highly accurate (±3–5 days).

Dating by last menstrual period (LMP) is less reliable due to recall error, irregular cycles, or ovulation variability. Second-trimester ultrasound provides reasonable accuracy but is less precise than first-trimester CRL (±7–10 days). Third-trimester ultrasound is the least accurate for dating because fetal growth variation increases significantly (±2–3 weeks). Symphysis-fundal height is useful for monitoring growth trends but not for precise dating.

In preterm labour management, correct gestational age influences decisions about corticosteroids, magnesium sulfate for neuroprotection, and neonatal resuscitation planning. Therefore, first-trimester CRL measurement is the gold standard for establishing gestational age.

This elderly man has classic lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) : hesitancy, straining, and incomplete emptying (obstructive symptoms). MCCQE objectives emphasize recognizing obstructive voiding symptoms in older men as most commonly due to prostatic enlargement causing bladder outlet obstruction.

First-line pharmacologic therapy for symptomatic BPH is an alpha-1 adrenergic receptor blocker (e.g., tamsulosin), which relaxes smooth muscle in the prostate and bladder neck, thereby improving urinary flow and reducing obstruction. Tamsulosin works relatively quickly and is appropriate for symptomatic relief.

Nitrofurantoin treats urinary tract infections, which are not suggested here. Fesoterodine is an antimuscarinic used for overactive bladder and could worsen urinary retention in obstructive BPH. Empagliflozin (an SGLT2 inhibitor) increases urinary glucose excretion and may worsen urinary frequency. Hydrochlorothiazide increases urine output and would not relieve obstructive symptoms.

Therefore, tamsulosin is the most appropriate medication to improve this patient’s symptoms.

Comprehensive and Detailed Explanation:

This patient likely has treatment-resistant obsessive-compulsive disorder (OCD), with classic symptoms of rumination, excessive guilt, and fear of causing harm. Clomipramine, a tricyclic antidepressant with strong serotonergic activity, is effective in treatment-resistant OCD and is often used after failure of multiple SSRIs or SNRIs.

Toronto Notes 2023 – Psychiatry, OCD:

“Clomipramine is a first-line tricyclic antidepressant for OCD, particularly after failed SSRI/SNRI trials. It is effective due to potent serotonergic action.”

MCCQE1 Objectives – Psychiatry > OCD and Anxiety Disorders:

“Candidates must identify treatment strategies for resistant OCD, including the role of clomipramine and augmentation therapy.”

Quetiapine (C) may be used as augmentation. Paroxetine (E) is another SSRI. Vortioxetine (A) and amitriptyline (D) are not first-line or preferred for OCD.

Comprehensive and Detailed Explanation:

The authority to license and regulate physicians to practise medicine is held by the medical regulatory colleges in each province or territory (e.g., CPSO in Ontario, CPSBC in BC).

MCC Objectives (ELOM > 90-1: Medical Regulation in Canada):

“Licensure to practise medicine is granted by the provincial or territorial medical regulatory authority.”

Toronto Notes 2023 – Ethics and Canadian Health Care System:

“Medical regulatory colleges determine physician licensure and discipline in each jurisdiction.”

The CFPC/RCPSC (C) certify physicians, not license them. Ministries of Health (A) oversee health policy, not licensing. Associations (E) advocate for physicians but do not regulate. Hospital boards (B) grant privileges, not licenses.